As a powerful antioxidant, it helps protect the body from oxidative stress, which is one of the factors associated with skin inflammation
(2014) ran a phase 2, randomised, double-blind, placebo-controlled proof-of-concept study (NCT00672074, sponsored by Helsinn Therapeutics (U.S.), Inc.) in bowel resection patients: 117 patients enrolled, of whom 114 composed the safety and modified intent-to-treat populations, receiving intravenous infusions of 0.03 mg/kg twice daily on postoperative day 1 to 7 or hospital discharge
CrossRef Association between early job loss and prognosis among hepatocellular carcinoma survivors B Yun, J Oh, S H Ahn, B K Kim, J-H Yoon Occupational Medicine.2025
Retrieved 24 February 2016